期刊文献+

细胞穿透肽应用的研究进展 被引量:5

Progress of Cell Penetrating Peptides Application as Delivery Agent
下载PDF
导出
摘要 细胞穿透肽是一类具有特殊细胞膜穿透作用的短肽,研究发现其为药物大分子物质的细胞内转运提供了有力工具,现已得到了广泛关注和大量研究.一方面,近年来发现,细胞穿透肽的应用面临着药物释放率、代谢降解、细胞系的分化状态和Rho-GTPases活性的依赖性等问题,从而阻碍了其研究开发的进程.另一方面,细胞穿透肽在肿瘤治疗、抗菌和抗炎靶向药物等方面的研究却取得了显著的进展,甚至进入了临床前和临床研究阶段.本文围绕细胞穿透肽在应用开发中所面临的挑战和机遇两方面,综述了近期的研究进展,并对细胞穿透肽在新领域中的应用进行了展望. Cell penetrating peptide (CPP) is a kind of small peptide with the capability of penetrating through cell membrane, which provides efficient tools for achieving intracellular access for macromolecular drugs. At present, it has obtained widespread attention and extensive research. Although it has been found recently that many problems hinder the process of its application research and development, such as drug release rate, metabolic degradation, cell lines and differentiation status and Rho GTPases activity dependence, lots of progress has been made in the research of CPPs in cancer treatment, antibacterial and anti-inflammatory targeted drugs, some of which even has entered the stage of preclinical and clinical research. In this article, we focus on two aspects, the challenges and new opportunities in the studies of CPP application, to summarize the recent research progress, and highlight the prospect of new fields of CPP application in the future.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2014年第8期731-738,共8页 Progress In Biochemistry and Biophysics
基金 国家重点基础研究发展计划(973)(2010CB529704) 国家自然科学基金(81030055) 广东省自然科学基金资助项目(10251051501000003) 教育部博士点基金项目(20104433120008) 2012年南方医科大学科研启动计划资助项目(B1012008) 广东省医学科学技术研究基金面上项目(A2013354)~~
关键词 细胞穿透肽 应用 研究进展 挑战 机遇 cell penetrating peptide (CPP), application, research progress, challenges, opportunities
  • 相关文献

参考文献46

  • 1Mussbach F,Franke M,Zoch A,et al.Transduction of peptides and proteins into live cells by cell penetrating peptides.J Cell Biochem,2011,112(12):3824-3833.
  • 2Chin Y L,Ali A,Chu C Y,et al.Visualizing a correlation between siRNA localization,cellular uptake,and RNAi in living cells.Chem Biol,2004,11(8):1165-1175.
  • 3El A S,Said H F,Boisguerin P,et al.Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.Methods Mol Biol,2011,764:75-89.
  • 4Rothbard J B,Garlington S,Lin Q,et al.Conjugation of arginine otigomers to cyclosporin A facilitates topical delivery and inhibition of inflammation.Nat Med,2000,6(11):1253-1257.
  • 5Santra S,Yang H,Stanley J T,et al.Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots.Chem Commun(Camb),2005,7(25):3144-3146.
  • 6Lewin M,Carlesso N,Tung C H,et al.Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.Nat Bioteclmol,2000,18(4):410-414.
  • 7Suhorutsenko J,Oskolkov N,Amkuusk P,et al.Cell-penetrating peptides,PepFects,show no evidence of toxicity and immunogenicity in vitro and in vivo.Bioconjug Chem,2011,22(11):2255-2262.
  • 8Taylor B N,Mehta R R,Yamada T,et al.Noncationic peptides obtained from azurin preferentially enter cancer cells.Cancer Res,2009,69(2):537-546.
  • 9Johansson H J,E1-Andaloussi S,Holm T,et al.Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein.Mol Ther,2008,16(1):115-123.
  • 10Fonseca S B,Pereira M P,Kelley S O.Recent advances in the use of cell-penetrating peptides for medical and biological applications.Adv Drug Deliv Rev,2009,61(11):953-964.

二级参考文献41

  • 1郭维锐,殷勤伟.siRNA诱导的DNA甲基化与肿瘤的发生[J].生物化学与生物物理进展,2006,33(1):10-16. 被引量:5
  • 2Doeppner T R, Nagel F, Dietz G P, et al. TAT-Hsp70-mediated neuroprotection and increased survival of neuronal precursor cells af- ter focal cerebral isehemia in mice. Cereb Blood Flow Metab,2009; 29(6) :1187-1196.
  • 3Liu Y, Huang R, Han L, et al. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycopro- tein RVG29 nanoparticles. Biomaterials,2009;30(25) :4195-4202.
  • 4Kumar P, Wu H, McBride J L, et ol. Transvascular delivery of small interfering RNA to the central nervous system. Nature, 2007;448 (7149) :39-43.
  • 5Bolhassani A. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Biochim Biophys Acta, 2011, 1816(2): 232-246.
  • 6Schroeder J A, Bitler B G. Anti-cancer therapies that utilize cell penetrating peptides. Recent Pat Anticancer Drug Discov, 2010, 5(2): 1-10.
  • 7King J E, Eugenin E A, Buckner C M, et al. HIV tat and neurotoxicity. Microbes Infect, 2006, 8(5): 1347 1357.
  • 8Weeks B S, Lieberman D M, Johnson B, et al. Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49-58 basic domain. J Neurosci Res, 1995, 42(1): 34-40.
  • 9Sabatier J M, Vives E, Mabrouk K, et al. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol, 1991, 65(2): 961-967.
  • 10Yi X, Zhao G, Zhang H J, et al. MITF-siRNA formulation is a safe and effective therapy for human melasma. Mol Ther, 2011, 19(2): 362-371.

共引文献4

同被引文献29

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部